Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Incyte Biosciences International Sàrl
Morges, Vaud, Switzerland
- Ownership
- Private
- Employees
- ~2500
- Development stage
- Other
01
Overview
Incyte’s clinical results have led to the commercialization of several drugs, notably Jakafi (ruxolitinib) for myeloproliferative neoplasms and GVHD, Pemazyre (pemigatinib) for cholangiocarcinoma, and Monjuvi (tafasitamab) for lymphoma. Opzelura (cream ruxolitinib) is approved for vitiligo and eczema. Incyte continues to progress other candidates in inflammation, hematology/oncology, and rare immune diseases, though recent pipeline rationalization has trimmed several immuno-oncology programs.
- Therapeutic areas
- HematologyOncologyDermatologyImmunology
- Modalities
- Small moleculeMonoclonal antibodyBispecific monoclonal antibodyCream formulation (topical drug)Antibody-drug conjugate
- Industry
- Biotech
02
Partnerships
MorphoSys (tafasitamab)Novartis (capmatinib/Tabrecta)Eli Lilly (baricitinib/Olumiant)Agenus (antibody discovery)Merus (bispecific antibody development)
Beyond the preview
Go deeper on Incyte Biosciences International Sàrl.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Incyte Biosciences International Sàrl.